Mortality and Technique Failure in Peritoneal Dialysis Patients Using Advanced Peritoneal Dialysis Solutions

SeungHyeok Han, Songvogue Ahn, Jee Young Yun, Anders Tranaeus, Dae Suk Han

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background: Despite the theoretical benefits of biocompatible physiological-pH bicarbonate/lactate-buffered (B/L) peritoneal dialysis solution, there is only limited evidence supporting a superior clinical outcome associated with its use. Study Design: Observational study. Settings & Participants: 2,163 patients starting peritoneal dialysis therapy between July 2003 and December 2006 from 54 centers in Korea were enrolled. Predictors: B/L solution and icodextrin use. Outcomes: All-cause mortality and technique failure. Measurements: Patient outcomes were compared between patients prescribed B/L and conventional solutions by using propensity score and intention-to-treat analyses. Results: 542 patients initiated peritoneal dialysis therapy with B/L solution, and 1,621, with conventional solution. Fifteen patients prescribed B/L solution switched to conventional solution, and 386 of those initially using conventional solution switched to B/L solution during follow-up. Propensity score matching yielded 542 matched pairs of patients. In the matched cohort, there were no significant differences in age, diabetes, cardiovascular comorbidity, socioeconomic status, icodextrin use, or center experience between the 2 groups. All-cause deaths occurred in 52 (9.6%) patients in the B/L-solution group compared with 102 (18.9%) in the conventional-solution group (hazard ratio [HR], 0.70; 95% confidence interval [CI], 0.50 to 0.98; P = 0.04). In addition, icodextrin use was significantly associated with a reduced risk of death (HR, 0.40; 95% CI, 0.28 to 0.58; P < 0.001). Thirty-three (6.1%) and 48 (8.9%) technique failures occurred in the B/L- and conventional-solution groups, respectively (HR, 0.91; 95% CI, 0.58 to 1.43; P = 0.7). The survival benefit of B/L solution persisted in the unmatched cohort (HR, 0.69; 95% CI, 0.52 to 0.93; P = 0.02). Limitations: Retrospective analysis, lack of laboratory data, and unknown indications for use of B/L solution. Conclusion: Use of a biocompatible B/L peritoneal dialysis solution with physiological pH is associated with improved survival compared with conventional solution. Large randomized clinical trials are warranted to confirm this finding.

Original languageEnglish
Pages (from-to)711-720
Number of pages10
JournalAmerican Journal of Kidney Diseases
Volume54
Issue number4
DOIs
Publication statusPublished - 2009 Oct 1

Fingerprint

Dialysis Solutions
Peritoneal Dialysis
Bicarbonates
Lactic Acid
Mortality
Confidence Intervals
Propensity Score
Intention to Treat Analysis
Survival
Korea
Social Class
Observational Studies
Comorbidity
Cause of Death

All Science Journal Classification (ASJC) codes

  • Nephrology

Cite this

@article{54aa553f7a704dc4aced9fa8f81652ce,
title = "Mortality and Technique Failure in Peritoneal Dialysis Patients Using Advanced Peritoneal Dialysis Solutions",
abstract = "Background: Despite the theoretical benefits of biocompatible physiological-pH bicarbonate/lactate-buffered (B/L) peritoneal dialysis solution, there is only limited evidence supporting a superior clinical outcome associated with its use. Study Design: Observational study. Settings & Participants: 2,163 patients starting peritoneal dialysis therapy between July 2003 and December 2006 from 54 centers in Korea were enrolled. Predictors: B/L solution and icodextrin use. Outcomes: All-cause mortality and technique failure. Measurements: Patient outcomes were compared between patients prescribed B/L and conventional solutions by using propensity score and intention-to-treat analyses. Results: 542 patients initiated peritoneal dialysis therapy with B/L solution, and 1,621, with conventional solution. Fifteen patients prescribed B/L solution switched to conventional solution, and 386 of those initially using conventional solution switched to B/L solution during follow-up. Propensity score matching yielded 542 matched pairs of patients. In the matched cohort, there were no significant differences in age, diabetes, cardiovascular comorbidity, socioeconomic status, icodextrin use, or center experience between the 2 groups. All-cause deaths occurred in 52 (9.6{\%}) patients in the B/L-solution group compared with 102 (18.9{\%}) in the conventional-solution group (hazard ratio [HR], 0.70; 95{\%} confidence interval [CI], 0.50 to 0.98; P = 0.04). In addition, icodextrin use was significantly associated with a reduced risk of death (HR, 0.40; 95{\%} CI, 0.28 to 0.58; P < 0.001). Thirty-three (6.1{\%}) and 48 (8.9{\%}) technique failures occurred in the B/L- and conventional-solution groups, respectively (HR, 0.91; 95{\%} CI, 0.58 to 1.43; P = 0.7). The survival benefit of B/L solution persisted in the unmatched cohort (HR, 0.69; 95{\%} CI, 0.52 to 0.93; P = 0.02). Limitations: Retrospective analysis, lack of laboratory data, and unknown indications for use of B/L solution. Conclusion: Use of a biocompatible B/L peritoneal dialysis solution with physiological pH is associated with improved survival compared with conventional solution. Large randomized clinical trials are warranted to confirm this finding.",
author = "SeungHyeok Han and Songvogue Ahn and Yun, {Jee Young} and Anders Tranaeus and Han, {Dae Suk}",
year = "2009",
month = "10",
day = "1",
doi = "10.1053/j.ajkd.2009.05.014",
language = "English",
volume = "54",
pages = "711--720",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "4",

}

Mortality and Technique Failure in Peritoneal Dialysis Patients Using Advanced Peritoneal Dialysis Solutions. / Han, SeungHyeok; Ahn, Songvogue; Yun, Jee Young; Tranaeus, Anders; Han, Dae Suk.

In: American Journal of Kidney Diseases, Vol. 54, No. 4, 01.10.2009, p. 711-720.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mortality and Technique Failure in Peritoneal Dialysis Patients Using Advanced Peritoneal Dialysis Solutions

AU - Han, SeungHyeok

AU - Ahn, Songvogue

AU - Yun, Jee Young

AU - Tranaeus, Anders

AU - Han, Dae Suk

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Background: Despite the theoretical benefits of biocompatible physiological-pH bicarbonate/lactate-buffered (B/L) peritoneal dialysis solution, there is only limited evidence supporting a superior clinical outcome associated with its use. Study Design: Observational study. Settings & Participants: 2,163 patients starting peritoneal dialysis therapy between July 2003 and December 2006 from 54 centers in Korea were enrolled. Predictors: B/L solution and icodextrin use. Outcomes: All-cause mortality and technique failure. Measurements: Patient outcomes were compared between patients prescribed B/L and conventional solutions by using propensity score and intention-to-treat analyses. Results: 542 patients initiated peritoneal dialysis therapy with B/L solution, and 1,621, with conventional solution. Fifteen patients prescribed B/L solution switched to conventional solution, and 386 of those initially using conventional solution switched to B/L solution during follow-up. Propensity score matching yielded 542 matched pairs of patients. In the matched cohort, there were no significant differences in age, diabetes, cardiovascular comorbidity, socioeconomic status, icodextrin use, or center experience between the 2 groups. All-cause deaths occurred in 52 (9.6%) patients in the B/L-solution group compared with 102 (18.9%) in the conventional-solution group (hazard ratio [HR], 0.70; 95% confidence interval [CI], 0.50 to 0.98; P = 0.04). In addition, icodextrin use was significantly associated with a reduced risk of death (HR, 0.40; 95% CI, 0.28 to 0.58; P < 0.001). Thirty-three (6.1%) and 48 (8.9%) technique failures occurred in the B/L- and conventional-solution groups, respectively (HR, 0.91; 95% CI, 0.58 to 1.43; P = 0.7). The survival benefit of B/L solution persisted in the unmatched cohort (HR, 0.69; 95% CI, 0.52 to 0.93; P = 0.02). Limitations: Retrospective analysis, lack of laboratory data, and unknown indications for use of B/L solution. Conclusion: Use of a biocompatible B/L peritoneal dialysis solution with physiological pH is associated with improved survival compared with conventional solution. Large randomized clinical trials are warranted to confirm this finding.

AB - Background: Despite the theoretical benefits of biocompatible physiological-pH bicarbonate/lactate-buffered (B/L) peritoneal dialysis solution, there is only limited evidence supporting a superior clinical outcome associated with its use. Study Design: Observational study. Settings & Participants: 2,163 patients starting peritoneal dialysis therapy between July 2003 and December 2006 from 54 centers in Korea were enrolled. Predictors: B/L solution and icodextrin use. Outcomes: All-cause mortality and technique failure. Measurements: Patient outcomes were compared between patients prescribed B/L and conventional solutions by using propensity score and intention-to-treat analyses. Results: 542 patients initiated peritoneal dialysis therapy with B/L solution, and 1,621, with conventional solution. Fifteen patients prescribed B/L solution switched to conventional solution, and 386 of those initially using conventional solution switched to B/L solution during follow-up. Propensity score matching yielded 542 matched pairs of patients. In the matched cohort, there were no significant differences in age, diabetes, cardiovascular comorbidity, socioeconomic status, icodextrin use, or center experience between the 2 groups. All-cause deaths occurred in 52 (9.6%) patients in the B/L-solution group compared with 102 (18.9%) in the conventional-solution group (hazard ratio [HR], 0.70; 95% confidence interval [CI], 0.50 to 0.98; P = 0.04). In addition, icodextrin use was significantly associated with a reduced risk of death (HR, 0.40; 95% CI, 0.28 to 0.58; P < 0.001). Thirty-three (6.1%) and 48 (8.9%) technique failures occurred in the B/L- and conventional-solution groups, respectively (HR, 0.91; 95% CI, 0.58 to 1.43; P = 0.7). The survival benefit of B/L solution persisted in the unmatched cohort (HR, 0.69; 95% CI, 0.52 to 0.93; P = 0.02). Limitations: Retrospective analysis, lack of laboratory data, and unknown indications for use of B/L solution. Conclusion: Use of a biocompatible B/L peritoneal dialysis solution with physiological pH is associated with improved survival compared with conventional solution. Large randomized clinical trials are warranted to confirm this finding.

UR - http://www.scopus.com/inward/record.url?scp=70349382812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349382812&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2009.05.014

DO - 10.1053/j.ajkd.2009.05.014

M3 - Article

C2 - 19619922

AN - SCOPUS:70349382812

VL - 54

SP - 711

EP - 720

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 4

ER -